Recombinant
RabMAb

Recombinant Anti-VCAM1 antibody [EPR5038(2)] (ab174279)

Rabbit recombinant monoclonal VCAM1 antibody [EPR5038(2)]. Validated in WB, IP and tested in Mouse, Rat, Human. Cited in 5 publication(s).

Publishing research using ab174279? Please let us know so that we can cite the reference in this datasheet.

ab174279 has been referenced in 7 publications.

  • Xu L  et al. Peroxisome Proliferator-Activated Receptor-? Antagonizes LOX-1-Mediated Endothelial Injury by Transcriptional Activation of miR-590-5p. PPAR Res 2019:2715176 (2019). PubMed: 31354796
  • Belcher JD  et al. Oral carbon monoxide therapy in murine sickle cell disease: Beneficial effects on vaso-occlusion, inflammation and anemia. PLoS One 13:e0205194 (2018). PubMed: 30308028
  • Cho RL  et al. Heme oxygenase-1 induction by rosiglitazone via PKCa/AMPKa/p38 MAPKa/SIRT1/PPAR? pathway suppresses lipopolysaccharide-mediated pulmonary inflammation. Biochem Pharmacol 148:222-237 (2018). PubMed: 29309760
  • Belcher JD  et al. Control of Oxidative Stress and Inflammation in Sickle Cell Disease with the Nrf2 Activator Dimethyl Fumarate. Antioxid Redox Signal 26:748-762 (2017). PubMed: 26914345
  • Yang CM  et al. ß-Catenin promotes cell proliferation, migration, and invasion but induces apoptosis in renal cell carcinoma. Onco Targets Ther 10:711-724 (2017). PubMed: 28260916
  • Yamamoto H  et al. Autocrine VEGF Isoforms Differentially Regulate Endothelial Cell Behavior. Front Cell Dev Biol 4:99 (2016). PubMed: 27709112
  • Wang Y  et al. Artemisinin inhibits monocyte adhesion to HUVECs through the NF-?B and MAPK pathways in vitro. Int J Mol Med 37:1567-75 (2016). WB . PubMed: 27122190

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Sign up